SS
Samba Sivarao Arigela
About Samba Sivarao Arigela
Data last updated:
Samba Sivarao Arigela is a Managing Director at Bhavyas Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma. Bhavyas Pharmaceuticals Private Limited reported revenue of ₹2.83 Cr (FY 2025). Earlier, Samba Sivarao Arigela was a Director at Nalkem Pharma Private Limited (2021–2022) and Director at Eagle Square Consulting Services Private Limited (from 2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bhavyas Pharmaceuticals Private Limited U24239TG2019PTC132290 | Managing Director | 01 Aug 2023 | 2019 | ₹2.83 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nalkem Pharma Private Limited U24304TG2021PTC153370 | Director | 22 Jul 2021 | 2021 | ₹1.02 Cr (FY 2025) | Active |
| Eagle Square Consulting Services Private Limited U74900PN2015PTC154097 | Director | 19 Feb 2015 | 2015 | ₹93,646 (FY 2016) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Samba Sivarao Arigela
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anji Reddy Nandipati | 08433778 | Bhavyas Pharmaceuticals Private Limited | Director |
| Mandepudi Kirankumar | 08592391 | Bhavyas Pharmaceuticals Private Limited | Director |
| Naresh Ponduri | 08433779 | Bhavyas Pharmaceuticals Private Limited | Director |
| Subhani Sheik | 07111567 | Bhavyas Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samba Sivarao Arigela
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samba Sivarao Arigela
Samba Sivarao Arigela currently holds 1 directorship: Bhavyas Pharmaceuticals Private Limited (Managing Director, since 01 Aug 2023, revenue ₹2.83 Cr (FY 2025)).
Samba Sivarao Arigela was first appointed on 19 Feb 2015 as Director at Eagle Square Consulting Services Private Limited. The most recent appointment on record is 01 Aug 2023 at Bhavyas Pharmaceuticals Private Limited.
Samba Sivarao Arigela held 2 earlier board appointments: Nalkem Pharma Private Limited (Director, 22 Jul 2021 to 07 Jan 2022); Eagle Square Consulting Services Private Limited (Director, from 19 Feb 2015).
The current boards of Samba Sivarao Arigela's companies include Anji Reddy Nandipati (Bhavyas Pharmaceuticals Private Limited), Mandepudi Kirankumar (Bhavyas Pharmaceuticals Private Limited), Naresh Ponduri (Bhavyas Pharmaceuticals Private Limited), Subhani Sheik (Bhavyas Pharmaceuticals Private Limited).